(Q45285614)

11 December 2017

Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis (English)

1 reference

11 December 2017

Ryushi Tazawa

1

1 reference

11 December 2017

Emi Hamano

2

1 reference

11 December 2017

Toru Arai

3

1 reference

11 December 2017

Hiromitsu Ohta

4

1 reference

11 December 2017

Osamu Ishimoto

5

1 reference

11 December 2017

Kanji Uchida

6

1 reference

11 December 2017

Masato Watanabe

7

1 reference

11 December 2017

Junichi Saito

8

1 reference

11 December 2017

Miki Takeshita

9

1 reference

11 December 2017

Yasuhiko Hirabayashi

10

1 reference

11 December 2017

Ikuo Ishige

11

1 reference

11 December 2017

Yoshinobu Eishi

12

1 reference

11 December 2017

Koichi Hagiwara

13

1 reference

11 December 2017

Masahito Ebina

14

1 reference

11 December 2017

Yoshikazu Inoue

15

1 reference

11 December 2017

Koh Nakata

16

1 reference

11 December 2017

Toshihiro Nukiwa

17

1 reference

11 December 2017

language of work or name

English

0 references

publication date

25 February 2005

1 reference

American Journal of Respiratory and Critical Care Medicine

11 December 2017

1 reference

11 December 2017

171

1 reference

11 December 2017

10

1 reference

11 December 2017

1142-1149

1 reference

Pulmonary Alveolar Proteinosis

11 December 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Pulmonary alveolar proteinosis: progress in the first 44 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Gm-CSF regulates pulmonary surfactant homeostasis and alveolar macrophage-mediated innate host defense

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Involvement of granulocyte-macrophage colony-stimulating factor in pulmonary homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Mice deficient for the IL-3/GM-CSF/IL-5 beta c receptor exhibit lung pathology and impaired immune response, while beta IL3 receptor-deficient mice are normal

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Relationship of anti-GM-CSF antibody concentration, surfactant protein A and B levels, and serum LDH to pulmonary parameters and response to GM-CSF therapy in patients with idiopathic alveolar proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

Bronchoalveolar Lavage Cell Data in Alveolar Proteinosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

The effect of aerosolized recombinant human granulocyte macrophage colony-stimulating factor on lung leukocytes in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200406-716OC

10.1164/RCCM.200406-716OC

21 January 2018

Identifiers

DOI

1 reference

release_s6dm5x2gzvgmndhisn5l4v5hxm

11 December 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/s6dm5x2gzvgmndhisn5l4v5hxm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference